- Home
- EXEL vs DRS Comparison
EXEL vs DRS Comparison
Compare EXEL & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- DRS
- Stock Information
- Founded
- EXEL 1994
- DRS 1969
- Country
- EXEL United States
- DRS United States
- Employees
- EXEL N/A
- DRS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- DRS Military/Government/Technical
- Sector
- EXEL Health Care
- DRS Industrials
- Exchange
- EXEL Nasdaq
- DRS Nasdaq
- Market Cap
- EXEL 11.3B
- DRS 11.8B
- IPO Year
- EXEL 2000
- DRS N/A
- Fundamental
- Price
- EXEL $44.08
- DRS $45.86
- Analyst Decision
- EXEL Buy
- DRS Strong Buy
- Analyst Count
- EXEL 18
- DRS 7
- Target Price
- EXEL $43.00
- DRS $42.00
- AVG Volume (30 Days)
- EXEL 3.3M
- DRS 1.6M
- Earning Date
- EXEL 08-05-2025
- DRS 07-30-2025
- Dividend Yield
- EXEL N/A
- DRS 0.77%
- EPS Growth
- EXEL 237.58
- DRS 25.90
- EPS
- EXEL 2.20
- DRS 0.88
- Revenue
- EXEL $2,298,922,000.00
- DRS $3,345,000,000.00
- Revenue This Year
- EXEL $9.37
- DRS $9.80
- Revenue Next Year
- EXEL $11.05
- DRS $6.39
- P/E Ratio
- EXEL $19.98
- DRS $52.87
- Revenue Growth
- EXEL 24.49
- DRS 13.58
- 52 Week Low
- EXEL $21.82
- DRS $22.73
- 52 Week High
- EXEL $49.62
- DRS $46.96
- Technical
- Relative Strength Index (RSI)
- EXEL 57.96
- DRS 56.21
- Support Level
- EXEL $42.66
- DRS $42.18
- Resistance Level
- EXEL $49.62
- DRS $46.16
- Average True Range (ATR)
- EXEL 1.58
- DRS 1.76
- MACD
- EXEL 0.10
- DRS -0.29
- Stochastic Oscillator
- EXEL 43.24
- DRS 50.63
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.